- Record: found
- Abstract: not found
- Article: not found
Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
Al B. Benson ,
Alan P. Venook ,
Mahmoud M. Al-Hawary ,
Lynette Cederquist ,
Yi-Jen Chen ,
Kristen K. Ciombor ,
Stacey Cohen ,
Harry S. Cooper ,
Dustin Deming ,
Paul F. Engstrom ,
Jean L. Grem ,
Axel Grothey ,
Howard S. Hochster ,
Sarah Hoffe ,
Steven Hunt ,
Ahmed Kamel ,
Natalie Kirilcuk ,
Smitha Krishnamurthi ,
Wells A. Messersmith ,
Jeffrey Meyerhardt ,
Mary F. Mulcahy ,
James D. Murphy ,
Steven Nurkin ,
Leonard Saltz ,
Sunil Sharma ,
David Shibata ,
John M. Skibber ,
Constantinos T. Sofocleous ,
Elena M. Stoffel ,
Eden Stotsky-Himelfarb ,
Christopher G. Willett ,
Evan Wuthrick ,
Kristina M. Gregory ,
Lisa Gurski ,
Deborah A. Freedman-Cass
July 13 2018
July 13 2018
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Rectal Cancer
address diagnosis, staging, surgical management, perioperative treatment, management
of recurrent and metastatic disease, disease surveillance, and survivorship in patients
with rectal cancer. This portion of the guidelines focuses on the management of localized
disease, which involves careful patient selection for curative-intent treatment options
that sequence multimodality therapy usually comprised of chemotherapy, radiation,
and surgical resection.